| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |